Clinical trial
Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel…
NCT00322400 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00322400 |
|---|---|
| Title | Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer |
| Official title | An Open-label, Dose-finding Study to Evaluate the Safety of AMG 706 in Combination With Paclitaxel or Docetaxel as Treatment for Locally Recurrent or Metastatic Breast Cancer |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Locally Recurrent and Metastatic Breast Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel, Paclitaxel, AMG 706 |
| Enrollment | 46 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Jan 1, 2012 |
| First posted | May 5, 2006 |
| Last update posted | Jul 31, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: